Clinical Trial Update: Optimizing 6-mercaptopurine Therapy in Pediatric Acute Lymphoblastic Leukemia by Using Allopurinol [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring optimization of 6-mercaptopurine therapy for pediatric acute lymphoblastic leukemia using allopurinol.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• 6-mercaptopurine (6-mercaptopurine)
• Allopurinol (Allopurinol)

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Lymphoblastic Leukemia, Acute, Childhood | Phase 2 | Status: UNKNOWN